Provention Bio

Company Drug

Q1 2023 financial report: AstraZeneca leads innovation in China, Sanofi’s sales in China decline

Fineline Cube Apr 28, 2023

Several multinational companies (MNCs) have released their Q1 2023 financials, showing a varied performance over...

Company Deals

Insight Lifetech Debuts on Shanghai STAR Market with $3 Billion Valuation, Breaking Import Monopoly in Cardiovascular Imaging

Company Drug

Fosun Pharma’s Fumaining Wins Priority Review for NF1 Adult Indication in China

Company Drug

Hengrui Pharma Secures NMPA Nod for SHR-1894 Atopic Dermatitis Trial

Company Drug

Akeso’s Ivonescimab Secures Fifth Breakthrough Therapy Designation for Biliary Tract Cancer in China